Eone Diagnomics Genome Center Co Ltd
KOSDAQ:245620
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Eone Diagnomics Genome Center Co Ltd
Gross Profit
Eone Diagnomics Genome Center Co Ltd
Gross Profit Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E
|
Eone Diagnomics Genome Center Co Ltd
KOSDAQ:245620
|
Gross Profit
₩2.8B
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
|
Samsung Biologics Co Ltd
KRX:207940
|
Gross Profit
₩2.5T
|
CAGR 3-Years
20%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
|
A
|
ADM Korea Inc
KOSDAQ:187660
|
Gross Profit
₩33.6m
|
CAGR 3-Years
-80%
|
CAGR 5-Years
-66%
|
CAGR 10-Years
N/A
|
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Gross Profit
₩1.5B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
6%
|
CAGR 10-Years
5%
|
|
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Gross Profit
₩136.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
47%
|
CAGR 10-Years
10%
|
|
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Gross Profit
₩126B
|
CAGR 3-Years
92%
|
CAGR 5-Years
29%
|
CAGR 10-Years
61%
|
|
Eone Diagnomics Genome Center Co Ltd
Glance View
EONE DIAGNOMICS GENOME CENTER Co., Ltd. engages in the operation as a genomics company providing a range of clinical and consumer genetic services. The company is headquartered in Incheon, Incheon. The company went IPO on 2018-06-26. The firm is engaged in non-invasive prenatal tests (NIPT), newborn screening tests, ophthalmologist specialist genome analysis tests, customized disease prediction tests, and direct to consumer (DTC) genetic tests, among others. In addition, the Company is developing genome-related software.
See Also
What is Eone Diagnomics Genome Center Co Ltd's Gross Profit?
Gross Profit
2.8B
KRW
Based on the financial report for Sep 30, 2025, Eone Diagnomics Genome Center Co Ltd's Gross Profit amounts to 2.8B KRW.
What is Eone Diagnomics Genome Center Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
-30%
Over the last year, the Gross Profit growth was -53%. The average annual Gross Profit growth rates for Eone Diagnomics Genome Center Co Ltd have been -40% over the past three years , -30% over the past five years .
